Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Gothelf, D. Articles by Apter, A. Search for Related Content PubMed Citation Articles by Gothelf, D. Articles by Apter, A. Child/Adolescent Psychiatry Schizophrenia Spectrum Disorders Other Neuroleptics

Weight Gain Associated With Increased Food Intake and Low Habitual Activity Levels in Male Adolescent Schizophrenic Inpatients Treated With Olanzapine

OBJECTIVE: The authors studied weight gain mechanisms and energy balance in patients treated with olanzapine. METHOD: The body mass index of male schizophrenic adolescent inpatients treated with olanzapine (N=10) and of 10 matched patients treated with haloperidol (N=10) were measured at baseline and after 4 weeks of treatment. For the patients treated with olanzapine, caloric intake, resting energy expenditure, and physical activity (determined through accelerometry and heart rate monitoring) were assessed at baseline and after 4 weeks of treatment. RESULTS: Body mass index significantly increased in those treated with olanzapine but not in those given haloperidol. The increase in body mass index was due to an increase in caloric intake without change in diet composition. Olanzapine had no significant effect on resting energy expenditure. Daily energy expenditure was very low before and after treatment. CONCLUSIONS: Olanzapine-induced weight gain is associated with a general increase in caloric intake.

This article has been cited by other articles:

				S. Kumra, J. V. Oberstar, L. Sikich, R. L. Findling, J. M. McClellan, S. Vinogradov, and S. Charles Schulz Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia Schizophr Bull, January 1, 2008; 34(1): 60 - 71. [Abstract] [Full Text] [PDF]

				G.D. Cooper, L.C. Pickavance, J.P.H. Wilding, J.A. HarroLd, J.C.G. HaLford, and A.J. Goudie Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities J Psychopharmacol, June 1, 2007; 21(4): 405 - 413. [Abstract] [PDF]

				S. F. Kim, A. S. Huang, A. M. Snowman, C. Teuscher, and S. H. Snyder From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase PNAS, February 27, 2007; 104(9): 3456 - 3459. [Abstract] [Full Text] [PDF]

				M. B. ISAAC and M. T. ISAAC Olanzapine and Weight Gain Am J Psychiatry, September 1, 2005; 162(9): 1764 - 1765. [Full Text] [PDF]

				M. Ader, S. P. Kim, K. J. Catalano, V. Ionut, K. Hucking, J. M. Richey, M. Kabir, and R. N. Bergman Metabolic Dysregulation With Atypical Antipsychotics Occurs in the Absence of Underlying Disease A Placebo-Controlled Study of Olanzapine and Risperidone in Dogs Diabetes, March 1, 2005; 54(3): 862 - 871. [Abstract] [Full Text] [PDF]

				K. A. Graham, D. O. Perkins, L. J. Edwards, R. C. Barrier Jr., J. A. Lieberman, and J. B. Harp Effect of Olanzapine on Body Composition and Energy Expenditure in Adults With First-Episode Psychosis Am J Psychiatry, January 1, 2005; 162(1): 118 - 123. [Abstract] [Full Text] [PDF]

				A. J. Zametkin, C. K. Zoon, H. W. Klein, and S. Munson Psychiatric Aspects of Child and Adolescent Obesity: A Review of the Past 10 Years Focus, October 1, 2004; 2(4): 625 - 641. [Abstract] [Full Text] [PDF]

				A. Martin, L. Scahill, G. M. Anderson, M. Aman, L. E. Arnold, J. McCracken, C. J. McDougle, E. Tierney, S. Chuang, B. Vitiello, et al. Weight and Leptin Changes Among Risperidone-Treated Youths With Autism: 6-Month Prospective Data Am J Psychiatry, June 1, 2004; 161(6): 1125 - 1127. [Abstract] [Full Text] [PDF]

				M. Peet Diet, diabetes and schizophrenia: review and hypothesis The British Journal of Psychiatry, April 1, 2004; 184(47): s102 - s105. [Abstract] [Full Text] [PDF]

				M. Poyurovsky, I. Isaacs, C. Fuchs, M. Schneidman, S. Faragian, R. Weizman, and A. Weizman Attenuation of Olanzapine-Induced Weight Gain With Reboxetine in Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study Am J Psychiatry, February 1, 2003; 160(2): 297 - 302. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us